The ilegx Vision
Educating Best Practice
Sponsorship
ilegx pirechart
Interdisciplinary Leg Initiative

3rd ilegx annual meeting
11-12 April 2011
an integral part of the
Charing Cross Symposium


3rd ilegx annual meeting


We learned in the first two ilegx annual meetings that the key to success was both early referral to a specialist centre and interdisciplinary team working to save legs

The 3rd ilegx annual meeting tackles the four major causes of amputation. It will be an integral part of the 33rd Charing Cross International Symposium, which attracts a multi-disciplinary audience of vascular specialists from around the world. In 2010, 2750 delegates attended from 75 countries.

ilegx in the UK

BIBA Medical has been awarded the opportunity to arrange various innovation showcases alongside the newspapers and this provides an unexpected opportunity to project the ilegx concept - just where it needs to be heard - in the heart of Government and health policy circles surrounded by very senior leaders of health technology companies. Therefore the ilegx programme directors will introduce the ilegx interdisciplinary leg initiative at the Healthcare Innovation Expo to be held on the 9-10 March 2011 in ExCel, London, UK. This event is supported by the Department of Health and the NHS and aims to be one of the top 5 global healthcare innovation events attracting 10,000 delegates.

Register here - coming soon

3rd ilegx annual meeting
Preliminary programmeTackling The Four Major Causes of Amputation

DAY 1

ilegx-APWCA transatlantic sessionChairman: R. Greenhalgh, UK

11:00-11:10
Introduction
R. Greenhalgh, UK

11:10-11:30 ilegx PhilosophyM. Edmonds, UK
D. Mayer, CH
G. Tepe, D

11:30-12:00
Transatlantic Effort To Reduce Amputation
S. Kravitz, USA

12:00-13:00
Necrosis, Apoptosis, Senescence enlightened
D. McCord, USA

13:00-14:30
LUNCH/EXHIBITION

Infection & NeuropathyChairman: M. Edmonds, UK

14:30-14:40
MRSA and other Multiresistant Organisms
R. Strohal, Austria

14:40-14:50
Discussion

14:50-15:00
Best Choice Antibiotics
T. Ruf, CH

15:00-15:10
Discussion

15:10-15:30
Interactive Case Presentation 1
M. Edmonds, UK

15:30-15:40
Compliance and Behaviour of Diabetics
Loretta Vileikyte, UK

15:40-15:50
Discussion

15:50-16:00
Management of Neuropathy
A. Bolton, Manchester UK

16:00-16:10
Discussion

16:10-17:00
Interactive Case Presentation 2, 3 and 4
M. Edmonds, UK

17:00-18:00
INDUSTRY RECEPTION

DAY 2

Ischemia I - Endovascular First

Chairman: G. Tepe, D

09:00-09:10
Extreme Interventions
L. Graziani, I

09:10-09:20
Discussion

09:20-09:30
Subintimal angioplasty in Diabetics
A. Bolia, UK

09:30-09:40
Discussion

09:40-09:50
Early Endovascular Treatment Reason for Drop of Amputation Rate?
P. Huppert, D

09:50-10:00
Discussion

Ischemia II - Vascular Surgery

Chairman: D. Mayer, CH

10:00-10:10
Distribution of Arterial Disease
I. Baumgartner, CH

10:10-10:20
Discussion

10:20-10:30
Limb Salvage in the Renal Patient
H. Rashid, UK

10:30-10:40
Discussion

10:40-11:30
Ischemia III - Vascular Debate
G. Clerici, i

10:40-11:30
ilex great debate including case presentation:
Dedicated below the knee endovascular intervention is the gold standard rather than distal bypass

For:
I. Baumgartner, CHG. Tepe, D
Against: M. Edmonds, UKD. Mayer,
CH

11:30-12:30
LUNCH/EXHIBITION

Charcot Foot Chairman: M. Edmonds, UK

12:30-12:40
Early Diagnosis of Charcot Disease
G. Clerici, I

12:40-12:50
Discussion

12:50-13:00
Mechanisms of Charcot Disease
N. Petrova, UK

13:00-13:10
Discussion

13:10-13:20
Management of Charcot Disease
T. Böni, CH

13:20-13:30
Discussion

13:30-14:00
Interactive Case Presentations 6 and 7
M. Edmonds, UK

14:00-14:30
Meeting Summary
R. Greenhalgh, UK

14:00-14:10
Neuropathy and Carcot
M. Edmonds, UK

14:10-14:20
Endovascular First
G. Tepe, D

14:20-14:30
Vascular Surgery
D. Mayer, CH


Partners


cordis

APWCA

LEG CLUB

Circulation foundation